Discover How ToxTracker® Provides Faster, Better Risk Assessment for Tobacco/Nicotine Products Manufacturers
ToxTracker® is a state-of-the-art reporter assay that can identify the (geno)toxic and potentially carcinogenic properties of chemicals and mixtures in a single test. It provides insight into the mode of action of toxic compounds, which can be crucial for reliable chemical safety assessment.
In this webinar, you will discover:
Possibility of FDA opening the door for 21st century in vitro toxicology assays as they move away from in vivo and add to the current “historical” testing requirements.
How ToxTracker® works.
ToxTracker® benefits compared to AMES, MN, and NRU (current) testing requirements for tobacco/nicotine.
Preliminary work at Labstat with ToxTracker.®
Enter Your Information to Watch Now
Ready to Use ToxTracker®?
Giel Hendriks Ph.D.
CEO of Toxys
Giel Hendriks has a Ph.D. in molecular cell biology from Utrecht University and worked for four years as a post-doctoral fellow in at Leiden University, studying the relationship between DNA damage and gene mutations. After this he moved to the Leiden University Medical Center to develop in vitro reporter systems to understand the mechanisms of genotoxicity. In 2014, he obtained financing to start Toxys. In 2016, he attracted various investors that allowed Toxys to setup their own laboratory at the Leiden Bio Science Park. As CEO of Toxys, he worked to develop the company into an internationally recognised contract research organisation (CRO) in chemical safety testing for industry. During the past years, Toxys has developed various in vitro assays to ensure the safety of novel medicines, chemicals, and consumer products without the use of animals.
Willie McKinney Ph.D.
CEO of McKinney Regulatory Science Advisors, LLC
Willie J. McKinney, Ph.D. is the founder and CEO of McKinney Regulatory Science Advisors, LLC, a company focused on converting scientific and regulatory challenges into business opportunities. He is a diplomate of the American Board of Toxicology and one of the world’s leading experts on the interface between science and government regulatory issues. He has devoted his career as a toxicologist in academia and industry to reducing the harm caused by tobacco. A former industry representative to the FDA’s Tobacco Product Scientific Advisory Committee (TPSAC) and senior scientist/executive at global tobacco and vaping companies, he’s intimately familiar with the workings of regulatory bodies in the United States and around the world.
Katarina Aleksa, Ph.D.
Senior Director Commercial Product Development & Regulatory Affairs – Toxicology/Microbiology, Labstat International Inc.
Katarina Skolnik-Aleksa, Ph.D. is a pharmacologist-toxicologist who earned her Ph.D. at the University of Toronto. She has focused her career on harm reduction and the effect of the environment on human health. She has worked in academia and research institutes in a variety of different roles. In 2020, she joined Labstat and is currently leading the CPD & Regulatory Affairs – Toxicology/Microbiology team. Her goal is to bring new 21st century in vitro toxicology assays to Labstat.